PDB23 SWITCHING TO INSULIN DEGLUDEC IS A COST-SAVING THERAPY FOR PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES IN THE SWEDISH SETTING BASED ON REAL WORLD DATA
Nov 1, 2019, 00:00 AM
10.1016/j.jval.2019.09.905
https://www.valueinhealthjournal.com/article/S1098-3015(19)33283-8/fulltext
Section Title :
Section Order :
10795
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33283-8&doi=10.1016/j.jval.2019.09.905